Variables | HIV status | Crude OR (95% CI) | Adjusted OR (95% CI) | |
---|---|---|---|---|
Positive | Negative | |||
Age at enrolment | ||||
≤ 6 weeks | 15 | 338 | 1.0 | 1.0 |
> 6 weeks | 36 | 120 | 6.76 (3.57, 12.79)* | 2.89 (1.35, 6.21)* |
Sex | ||||
Male | 26 | 237 | 0.97 (0.54, 1.73) | ** |
Female | 25 | 221 | 1.0 | |
Residence | ||||
Urban | 27 | 397 | 1.0 | 1.0 |
Rural | 24 | 61 | 5.79 (3.14, 10.67)* | 5.05 (2.34, 10.9)* |
Place of Birth | ||||
Health institution | 33 | 427 | 1.0 | 1.0 |
Home | 18 | 31 | 7.5 (3.81, 14.83) | 2.82 (1.2, 6.64) |
Maternal status | ||||
Alive | 47 | 451 | 1.0 | ** |
Dead | 4 | 7 | 5.48 (1.55, 19.42)* | |
Maternal PMTCT intervention | ||||
Yes | 20 | 397 | 1.0 | 1.0 |
No | 31 | 61 | 10.09 (5.41, 18.82)* | 5.02 (2.43, 10.4)* |
Infant feeding practice | ||||
Exclusive breast feeding | 26 | 371 | 1.0 | 1.0 |
Exclusive replacement feeding | 8 | 59 | 1.94 (0.84,4.48) | 1.72 (0.65, 4.53) |
Mixed feeding | 16 | 24 | 9.51 (4.51,20.08)* | 4.18 (1.59, 10.99)* |
History of infant ARV prophylaxis at birth | ||||
Received | 21 | 400 | 1.0 | |
Not Received | 30 | 44 | 12.99 (6.86, 24.6)* | ** |
Infant ARV prophylaxis during follow up | ||||
None | 30 | 45 | 8.22 (2.32, 29.10)* | ** |
sdNVP | 5 | 94 | 0.66 (0.15, 2.89) | |
sdNVP + AZT 7 days | 12 | 265 | 0.56 (0.15, 2.07) | |
sdNVP + AZT 4 weeks | 3 | 37 | 1.0 | |
Baseline Cotrimoxazole | ** | |||
Yes | 44 | 364 | 1.0 | |
No | 7 | 92 | 0.63 (0.28, 1.44) |